drugset / Trial / NCT04365270

Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer

NCT04365270

Phase 3 Completed 65 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

The study is a randomized clinical trial that assesses the clinical success and the antibacterial effect on carious dentine of glass ionomer when modified with Chitosan and/or Titanium dioxide nano particles vs the control group of modification with Chlorhexidine as control when used in primary molars

Timeline

Start
2019-01-15
Primary completion
2021-01-05
Completion
2021-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Chitosan Low Molecular Weight (20-200 Mpa.S) Unknown 10 %
Comparator Chlorhexidine Small molecule 0.5 %
Subject Titanium Dioxide Small molecule 3 %

Indications